Cardiovascular Systems Receives $3,500,000 New Round

  • Feed Type
  • Date
    12/14/2010
  • Company Name
    Cardiovascular Systems
  • Mailing Address
    651 Campus Drive St.Paul, MN 55112
  • Company Description
    Replidyne is a biopharmaceutical company focused on developing and commercializing innovative anti-infective products.
  • Website
    http://www.replidyne.com
  • Transaction Type
    Debt
  • Transaction Amount
    $3,500,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed. SEC regulatory filing.
  • M&A Terms
  • Venture Investor
    Undisclosed

Trending on Xconomy